Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study

Not Applicable

Completed

• Conditions: Acne Vulgaris

• Registration Number: NCT00206895
• Lead Sponsor: Bispebjerg Hospital

Brief Summary

The purpose of the study is to evaluated the efficacy and tolerability of methyl aminolevulinate and 5-aminolevulinic acid photodynamic therapy in patients with moderate to severe facial acne vulgaris in a randomized controlled and investigator blinded trial.

Detailed Description

Not available

Study Timeline

• Status Verified: 2004-10
• Study Start: 2004-11
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-21
• Last Update Submitted: 2006-10-10
• Last Update Posted: 2006-10-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

18 years or older, good health, more than 12 inflammatory facial acne lesions -

Exclusion Criteria

skin type VI, pregnant or lactating woman. Oral retinoid use within one year, systemic antibiotics within 1 month, topical acne treatment within 2 weeks.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Lesion counts (non-inflammatory and inflammatory)
Leeds Revised Acne Grading System

Secondary Outcome Measures

Name	Time	Method
Pain
Side effects

Trial Locations

Locations (1)

Bispebjerg Hospital; 🇩🇰 Copenhagen, Copenhagen NV, Denmark